TNSN01085A1 - Carboxyalkylether-acat inhibitor combinations - Google Patents

Carboxyalkylether-acat inhibitor combinations

Info

Publication number
TNSN01085A1
TNSN01085A1 TNTNSN01085A TNSN01085A TNSN01085A1 TN SN01085 A1 TNSN01085 A1 TN SN01085A1 TN TNSN01085 A TNTNSN01085 A TN TNSN01085A TN SN01085 A TNSN01085 A TN SN01085A TN SN01085 A1 TNSN01085 A1 TN SN01085A1
Authority
TN
Tunisia
Prior art keywords
carboxyalkylether
acat inhibitor
formula
inhibitor combinations
acat
Prior art date
Application number
TNTNSN01085A
Other languages
English (en)
Inventor
Jeffrey Auerbach Bruce
Lee Zobel Donna
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of TNSN01085A1 publication Critical patent/TNSN01085A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TNTNSN01085A 2000-06-07 2001-06-05 Carboxyalkylether-acat inhibitor combinations TNSN01085A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21005600P 2000-06-07 2000-06-07

Publications (1)

Publication Number Publication Date
TNSN01085A1 true TNSN01085A1 (en) 2005-11-10

Family

ID=22781424

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN01085A TNSN01085A1 (en) 2000-06-07 2001-06-05 Carboxyalkylether-acat inhibitor combinations

Country Status (14)

Country Link
EP (1) EP1292363A2 (es)
JP (1) JP2003535125A (es)
AR (1) AR034255A1 (es)
AU (1) AU2001263003A1 (es)
BR (1) BR0111428A (es)
CA (1) CA2413906A1 (es)
GT (1) GT200100106A (es)
MX (1) MXPA02010762A (es)
PA (1) PA8518601A1 (es)
PE (1) PE20020265A1 (es)
SV (1) SV2002000466A (es)
TN (1) TNSN01085A1 (es)
UY (1) UY26752A1 (es)
WO (1) WO2001093845A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387236B2 (en) 2001-10-09 2008-06-17 Delaware Capital Formation, Inc. Dispensing of currency

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69833971T2 (de) * 1998-01-28 2006-11-02 Warner-Lambert Co. Llc Verfahren zur behandlung der alzheimerschen krankheit

Also Published As

Publication number Publication date
JP2003535125A (ja) 2003-11-25
GT200100106A (es) 2002-05-20
BR0111428A (pt) 2003-06-10
WO2001093845A3 (en) 2002-10-10
AR034255A1 (es) 2004-02-18
EP1292363A2 (en) 2003-03-19
PA8518601A1 (es) 2002-07-30
AU2001263003A1 (en) 2001-12-17
CA2413906A1 (en) 2001-12-13
WO2001093845A2 (en) 2001-12-13
SV2002000466A (es) 2002-04-03
UY26752A1 (es) 2001-07-31
PE20020265A1 (es) 2002-04-19
MXPA02010762A (es) 2003-03-10

Similar Documents

Publication Publication Date Title
BG105428A (en) 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as cetp inhibitors
ATE267172T1 (de) 4-carboxyamino-2-methyl-1,2,3,4- tetrahydrochinoline als cetp-hemmer
MY136133A (en) New mandelic acid derivatives and their use as thrombin inhibitors
YU84603A (sh) Novi inhibitori tirozin kinaze
EP1163208A4 (en) CASPASE INHIBITORS AND THEIR USE
DE69529892D1 (de) BINDUNG VON E-SELECTIN, P-SELECTIN ODER L-SELECTIN AN SIALYL-LEWISx ODER AN SIALYL-LEWISa
MXPA04000411A (es) Tiazolidinonas arilo sustituidas y uso de las mismas.
MX9804623A (es) Precursores inactivos de farmacos inhibidores de trombina.
MXPA02012252A (es) Inhibidores de la reductasa 3-hidroxi-3-metilglutaril-coenzima a (hmg-coa) y metodo.
IL160769A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
AU2001274220A1 (en) Serine protease inhibitors
WO1999005096A3 (en) Urokinase inhibitors
SE9602646D0 (sv) Pharmaceutically-useful compounds
YU17202A (sh) Disperzioni preparati sa sadržajem inhibitora lipaza
HK1100659A1 (en) Hiv protease inhibiting compounds hiv
CO5261493A1 (es) Procedimiento y compuestos para la inhibicion de la mrp1
WO2002020475A3 (en) Inhibitors of serine protease activity of matriptase or mtsp1
ATE319680T1 (de) Substituierte 2-benzylamino-2-phenyl- acetamidverbindungen
ATE350443T1 (de) Biozid wirkendes reinigungsmittel
TNSN01085A1 (en) Carboxyalkylether-acat inhibitor combinations
SI1377574T1 (es)
ATE345581T1 (de) Trihydroxybenzen zur verhinderung der korrosion von titan
UA71004C2 (uk) Похідні 1-трифторометил-4-гідрокси-7-піперидиніламінометилхроману
DE69405760T2 (de) 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren
DOP2001000184A (es) Combinaciones de carboxialquileter-inhibidor de acat